Dr. Maria R. Tria Tirona
Claim this profileEdwards Comprehensive Cancer Center
Area of expertise
Lung Cancer
Maria R. Tria Tirona has run 19 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Maria R. Tria Tirona has run 12 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Edwards Comprehensive Cancer Center
Clinical Trials Maria R. Tria Tirona is currently running
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting
2 awards
Phase 3
Selumetinib + Olaparib
for Ovarian and Endometrial Cancer
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib to selumetinib alone in women with endometrial or ovarian (fallopian tube and primary peritoneal) cancer that has come back (recurrent) or that remains despite treatment (persistent) and harbors a mutation in the RAS pathway. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. The addition of olaparib to selumetinib could increase the percentage of tumors that shrink as well as lengthen the time that the tumors remain stable (without progression) as compared to selumetinib alone.
Recruiting
1 award
Phase 2
More about Maria R. Tria Tirona
Clinical Trial Related
9 years of experience running clinical trials · Led 36 trials as a Principal Investigator · 11 Active Clinical Trials
Treatments Maria R. Tria Tirona has experience with
- Pembrolizumab
- Carboplatin
- Paclitaxel
- Biospecimen Collection
- Gemcitabine Hydrochloride
- Nivolumab
Breakdown of trials Maria R. Tria Tirona has run
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maria R. Tria Tirona specialize in?
Maria R. Tria Tirona focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Maria R. Tria Tirona currently recruiting for clinical trials?
Yes, Maria R. Tria Tirona is currently recruiting for 11 clinical trials in Huntington West Virginia. If you're interested in participating, you should apply.
Are there any treatments that Maria R. Tria Tirona has studied deeply?
Yes, Maria R. Tria Tirona has studied treatments such as Pembrolizumab, Carboplatin, Paclitaxel.
What is the best way to schedule an appointment with Maria R. Tria Tirona?
Apply for one of the trials that Maria R. Tria Tirona is conducting.
What is the office address of Maria R. Tria Tirona?
The office of Maria R. Tria Tirona is located at: Edwards Comprehensive Cancer Center, Huntington, West Virginia 25701 United States. This is the address for their practice at the Edwards Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.